Published by Michele Maatouk on 18th December 2020
(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.
URL: http://www.digitallook.com/dl/news/story/31525925/...